Targeting Withdrawal Symptoms in Men Addicted to Methamphetamine With Transcranial Magnetic Stimulation: A Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 30208372.
- Also identified by DOI 10.1001/jamapsychiatry.2018.2383 and PMC identifier 6583874.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This randomized clinical trial examines the use of transcranial magnetic stimulation targeting the left dorsal-lateral prefrontal cortex to modulate withdrawal symptoms in men addicted to methamphetamine.
Medical subject headings
- Amphetamine-Related Disorders
- Substance Withdrawal Syndrome
- Transcranial Magnetic Stimulation